ESOPHAGEAL STENTING FOR MALIGNANT STENOSIS (three-year outcomes)

Por A. A. Avanesyan, N. S. Popova, B. I. Miroshnikov, V. M. Moiseenko
Publicado em 2020-03-01

Esophageal stenting for unresectable cancer (review of literature)

Por N. S. Popova, A. A. Avanesyan, B. I. Miroshnikov, V. M. Moiseenko
Publicado em 2021-01-01

Endoscopic submucosal dissection of large leiomyoma of the esophagus with subsequent closure of the defect with a mucosal flap

Por A. A. Avanesyan, A. E. Akkalaeva, B. I. Miroshnikov, V. M. Moiseenko
Publicado em 2019-04-01

THE FIRST EXPERIENCE OF ENDOSCOPIC FULLWALL RESECTION OF CANCER IN RECTUM

Por A. A. Avanesyan, A. E. Akkalaeva, M. U. Tsicoridze, B. I. Miroshnikov, V. M. Moiseenko
Publicado em 2018-02-01

Professor Boris Ivanovich Miroshnikov (to 80^th anniversary of his birthday)

Por S. A. Varzin, V. M. Moiseenko, G. G. Nakopiya, A. V. Starenchenko, B. I. Shulutko, P. K. Yablonsky
Publicado em 2017-12-01

Results of a unicenter randomized study of the safety and efficiency of docetaxel chemotherapy before radical prostatectomy in patients with intermediate- and high-risk prostate ca...

Por A. K. Nosov, S. B. Petrov, S. A. Reva, E. M. Mamizhev, R. V. Novikov, E. I. Veliev, V. M. Moiseenko
Publicado em 2014-12-01

Results of a unicenter randomized study of the safety and efficiency of docetaxel chemotherapy before radical prostatectomy in patients with intermediate- and high-risk prostate ca...

Por A. K. Nosov, S. B. Petrov, S. A. Reva, E. M. Mamizhev, R. V. Novikov, E. I. Veliev, V. M. Moiseenko
Publicado em 2014-12-01

BCD-100 - first russian PD-1 inhibitor

Por S A Tyulyandin, M Yu Fedyanin, T Yu Semiglazova, V M Moiseenko, S V Odintsova, B Ya Alekseev, R A Ivanov, M S Shustova
Publicado em 2017-09-01

MORPHOLOGIC AND MOLECULAR FEATURES OF PRIMARY GLIOBLASTOMA IN PATIENTS SURVIVING MORE THAN 3 YEARS

Por M. V. Matsko, D. E. Matsko, N. M. Volkov, A. Yu. Ulitin, V. M. Moiseenko, E. N. Imyanitov, A. G. Iyevleva
Publicado em 2019-06-01

Mineralization of the Peritoneum — a New Target in the Treatment of Peritoneal Carcinomatosis

Por Sh. Kh. Gantsev, V. M. Moiseenko, K. Sh. Gantsev, S. V. Solomenny, Sh. R. Kzyrgalin, V. A. Dokichev, F. V. Moiseenko, R. S. Minigazimov
Publicado em 2019-03-01

Bladder cancer. A retrospective analysis of the use of vinfluvin in real clinical practice

Por A. S. Zhabina, A. I. Novikov, F. V. Moiseenko, N. M. Volkov, E. O. Stepanova, E. V. Artemeva, N. H. Abduloeva, V. M. Moiseenko
Publicado em 2021-06-01

Intratumor morphologic and molecular genetic heterogeneity in astrocytomas of different grade of malignancy in the material from the first operation

Por D. E. Matsko, M. V. Matsko, A. O. Baksheeva, E. N. Imyanitov, A. Yu. Ulitin, V. M. Moiseenko, K. V. Shelekhova, N. M. Volkov, A. G. Ievleva, V. I. Tiurin, S. S. Sklyar, A. A. Zrelov, A. S. Morozova
Publicado em 2022-01-01

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients

Por A. A. Kashintsev, G. A. Yanus, N. Yu. Kokhanenko, V. M. Moiseenko, M. D. Hanevich, L. D. Roman, A. G. Ievleva, A. P. Sokolenko, E. N. Suspitsin, A. I. Budovskiy, A. V. Togo, N. M. Volkov, R. V. Fadeev, M. S. Dinikin, A. K. Ivanova, K. G. Shostko, E. N. Imyanitov
Publicado em 2016-02-01

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer

Por M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, L. V. Bolotina, F. V. Moiseenko, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, V. M. Moiseenko, А. А. Meshcheryakov, E. V. Artamonova, I. A. Pokataev, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, G. Z. Mukhametshina, R. V. Orlova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, V. M. Sherstnev, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, A. A. Tryakin, S. A. Tjulandin
Publicado em 2019-06-01